IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the fourth quarter and full year of 2019 after the close of trading on Thursday, March 12, 2020.  The Company’s management team will host a corresponding conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET.

Investors interested in listening to the conference call may do so by dialing (844) 707-0665 for domestic callers or (703) 326-3030 for international callers, using conference ID: 6384497.  A live and archived webcast of the event will be available on the “Investors” section of the Company’s website at: www.iridex.com.

About IRIDEXIRIDEX Corporation is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Company’s proprietary MicroPulse® technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions. IRIDEX’s current product line is used for the treatment of glaucoma and diabetic macular edema (DME) and other retinal diseases. IRIDEX products are sold in the United States through a direct sales force and internationally primarily through a network of independent distributors into more than 100 countries. For further information, visit the IRIDEX website at www.iridex.com.

Investor Relations Contact: Leigh Salvo (415) 937-5404 investors@iridex.com

Media Contact: Jamie Hall Pascale Communications, LLC. (724) 417-0167 pr@iridex.com

IRIDEX (NASDAQ:IRIX)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more IRIDEX Charts.
IRIDEX (NASDAQ:IRIX)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more IRIDEX Charts.